~~~~~~~~~~~~~~~~~~~~~~~~~~
FROI,
BOCL and WZE!!! ~~~~~~~~~~~~~~~~~~~~~~~~~~
Quick Links More On Us ~~~~~~~~~~~~~~~~~~~~~~~~~~
Join Our List Join Our Mailing List ~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~
FROI - Fero Industries, Inc.
FROI just hit a new 52 week high of .67 on 4x its average daily volume.
FROI is shaping up exactly how we thought it would. If
FROI continues to move to new highs and starts getting traction it could have a nice breakout increasing its price per share substantially. We are looking for that type of move relatively soon.
About Pyro Pharmaceuticals, Inc.
Pyro Pharmaceuticals, Inc. is developing therapeutics against multi-drug resistant infectious microorganisms or "Super Bugs." Pyro`s focus is on diseases in which antibiotic resistance has become a significant issue. Pyro`s plan is to develop a new class of antibiotics for a wide variety of disease causing microorganisms, especially those that have exhibited multiple drug resistance. Antibiotic resistance is a growing public health concern worldwide. According to the Center for Disease Control ("CDC"), antibiotic drug resistance has significantly increased mortality rates, making infectious disease the third largest cause of death in the United States. Drug resistance has also increased the cost of health care delivery. Examples of the types of bacteria that have become resistant to antibiotics include the species that cause skin infections, meningitis, sexually transmitted diseases, respiratory tract infections such as pneumonia and tuberculosis, and multi-drug resistant Staphylococcus aureus (
MRSA).
Pyro is a development stage company. Its plans and businesses are "proposed" and "intended," but it may not be able to successfully implement them with without funding. In addition, Pyro has not earned revenues and has incurred losses since its incorporation. As a development stage company, Pyro`s prospects are subject to all of the risks, expenses, and uncertainties frequently encountered by companies in the drug development and pharmaceutical business.
Recent news:
9:00 am EST, Tuesday November 10, 2009 Pyro Pharmaceuticals, Inc. Announces the Appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board 9:00 am EDT, Monday October 26, 2009 Pyro Pharmaceuticals, Inc. Discloses Information on its Ten Patent Applications 9:00 am EDT, Wednesday October 21, 2009 Fero Industries, Inc. Acquisition Target, Pyro Pharmaceuticals Appoints New Board Member ~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~
See Red Hot Penny Stock's website for full disclaimer. Red Hot Penny Stock may have received compensation for stock picks.
Home
